Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
24.92
+0.64 (2.64%)
At close: Dec 20, 2024, 4:00 PM
25.01
+0.09 (0.36%)
After-hours: Dec 20, 2024, 5:31 PM EST
Royalty Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 1,145 | 1,135 | 42.83 | 619.73 | 975.04 | 2,349 | Upgrade
|
| Depreciation & Amortization | - | - | 5.67 | 23 | 23.06 | 23.92 | Upgrade
|
| Other Amortization | 19.1 | 20.5 | 21.36 | 20.16 | 11.72 | 12.79 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 615.83 | - | 65.05 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -348.84 | -317.98 | 40.26 | 30.21 | -265.67 | -155.75 | Upgrade
|
| Loss (Gain) on Equity Investments | 15.17 | -10.06 | 48.12 | 53.87 | -2.13 | 46.58 | Upgrade
|
| Stock-Based Compensation | 2.44 | 2.36 | 2.17 | 2.44 | 5.43 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 491.91 | 560.66 | 904.24 | 452.84 | 230.84 | -2,668 | Upgrade
|
| Other Operating Activities | -1,529 | -1,609 | -2,076 | -1,484 | -1,207 | 149.9 | Upgrade
|
| Change in Accounts Receivable | 2,956 | 3,204 | 2,544 | 2,296 | 2,122 | 1,937 | Upgrade
|
| Change in Accounts Payable | 8.17 | 6.24 | 2.29 | -4.59 | -0.77 | 6.5 | Upgrade
|
| Change in Other Net Operating Assets | 39.02 | -3.44 | -6.08 | 8.4 | 76.36 | -33.64 | Upgrade
|
| Operating Cash Flow | 2,799 | 2,988 | 2,144 | 2,018 | 2,035 | 1,667 | Upgrade
|
| Operating Cash Flow Growth | 0.50% | 39.36% | 6.27% | -0.84% | 22.04% | 3.02% | Upgrade
|
| Sale (Purchase) of Intangibles | -3,012 | -2,116 | -1,742 | -2,192 | -2,182 | -1,721 | Upgrade
|
| Investment in Securities | -93.18 | 57.17 | 712.22 | 339.82 | -577.07 | -173.49 | Upgrade
|
| Other Investing Activities | -68 | -14.44 | - | -18.6 | - | -258.84 | Upgrade
|
| Investing Cash Flow | -3,173 | -2,073 | -1,029 | -1,870 | -2,759 | -2,154 | Upgrade
|
| Short-Term Debt Issued | - | 350 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 1,273 | 11,891 | - | Upgrade
|
| Total Debt Issued | 1,821 | 350 | - | 1,273 | 11,891 | - | Upgrade
|
| Short-Term Debt Repaid | - | -350 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1,000 | - | - | -11,210 | -294 | Upgrade
|
| Total Debt Repaid | -350 | -1,350 | - | - | -11,210 | -294 | Upgrade
|
| Net Debt Issued (Repaid) | 1,471 | -1,000 | - | 1,273 | 680.63 | -294 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,150 | - | Upgrade
|
| Repurchase of Common Stock | -207.24 | -304.76 | - | - | - | -4.27 | Upgrade
|
| Common Dividends Paid | -372.15 | -358.33 | -333.32 | -285.18 | -397.84 | -739.28 | Upgrade
|
| Other Financing Activities | -504.63 | -485.67 | -611.53 | -602.24 | 53.99 | -154.08 | Upgrade
|
| Financing Cash Flow | 387.21 | -2,149 | -944.86 | 385.11 | 1,487 | -1,192 | Upgrade
|
| Net Cash Flow | 13.6 | -1,234 | 169.7 | 532.37 | 762.48 | -1,678 | Upgrade
|
| Free Cash Flow | 2,799 | 2,988 | 2,144 | 2,018 | 2,035 | 1,667 | Upgrade
|
| Free Cash Flow Growth | 0.50% | 39.36% | 6.27% | -0.84% | 22.04% | 3.02% | Upgrade
|
| Free Cash Flow Margin | 123.53% | 126.89% | 95.83% | 88.12% | 95.87% | 91.90% | Upgrade
|
| Free Cash Flow Per Share | 4.70 | 4.96 | 4.90 | 4.86 | 5.42 | - | Upgrade
|
| Cash Interest Paid | 162.09 | 169.17 | 170.14 | 130.43 | 103.2 | 254.96 | Upgrade
|
| Levered Free Cash Flow | -2,120 | -1,245 | -1,384 | -1,547 | -1,087 | -341.12 | Upgrade
|
| Unlevered Free Cash Flow | -2,010 | -1,149 | -1,288 | -1,463 | -993.85 | -140.67 | Upgrade
|
| Change in Net Working Capital | -34.1 | -31.66 | 131.12 | 190.97 | -122.13 | 82.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.